RCAN1 antibody
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Description
Inhibits calcineurin-dependent transcriptional responses by binding to the catalytic domain of calcineurin A. Could play a role during central nervous system development.
Documents del producto
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | regulator of calcineurin 1 (RCAN1) |
| Host | Rabbit |
| Reactivity | Human, Mouse, Rat |
| Recommended Dilution | WB: 1:500-1:2000; IHC: 1:20-1:200 |
| Clonality | polyclonal |
| Conjugation | Unconjugated |
| Isotype | IgG |
| Observed MW | 25-29 kDa |
| Purity | ≥95% as determined by SDS-PAGE |
| Purification | Immunogen affinity purified |
| Size 1 | 100µg |
| Form | liquid |
| Tested Applications | ELISA, WB, IHC |
| Storage | PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.) |
| UniProt ID | P53805 |
| Gene ID | 1827 |
| Alias | Calcipressin-1,Adapt78,Down syndrome critical region protein 1,Myocyte-enriched calcineurin-interacting protein 1 (MCIP1),Regulator of calcineurin 1,RCAN1,ADAPT78,CSP1,DSC1,DSCR1 |
| Background | Antibody anti-RCAN1 |
| Status | RUO |
| Note | Mol. Weight 25-29 kDa |
Descripción
Related Products
Human RCAN1 (Calcipressin-1) ELISA Kit
Ver Producto
RCAN1 antibody
Inhibits calcineurin-dependent transcriptional responses by binding to the catalytic domain of calcineurin A. Could play a role during central nervous system development.
Ver Producto
Calcipressin-1 (RCAN1) Antibody
RCAN1 Antibody is a Rabbit Polyclonal antibody against RCAN1. The protein encoded by this gene interacts with calcineurin A and inhibits calcineurin-dependent signaling pathways, possibly affecting central nervous system development. This gene is located in the minimal candidate region for the Down syndrome phenotype, and is overexpressed in the brain of Down syndrome fetuses. Chronic overexpression of this gene may lead to neurofibrillary tangles such as those associated with Alzheimer disease. Alternative splicing results in multiple transcript variants.
Ver Producto